FI955463L - Menetelmä biologisesti aktiivisten polypeptidien tuottamiseksi rekombinanttitekniikalla - Google Patents

Menetelmä biologisesti aktiivisten polypeptidien tuottamiseksi rekombinanttitekniikalla Download PDF

Info

Publication number
FI955463L
FI955463L FI955463A FI955463A FI955463L FI 955463 L FI955463 L FI 955463L FI 955463 A FI955463 A FI 955463A FI 955463 A FI955463 A FI 955463A FI 955463 L FI955463 L FI 955463L
Authority
FI
Finland
Prior art keywords
biologically active
recombinant technology
active polypeptides
producing biologically
producing
Prior art date
Application number
FI955463A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955463A0 (fi
FI955463A7 (fi
Inventor
Kimishige Ishizaka
Yun-Cai Liu
Toshifumi Mikayama
Original Assignee
Jolla Inst Allergy Immunolog
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Inst Allergy Immunolog, Kirin Brewery filed Critical Jolla Inst Allergy Immunolog
Publication of FI955463A0 publication Critical patent/FI955463A0/fi
Publication of FI955463A7 publication Critical patent/FI955463A7/fi
Publication of FI955463L publication Critical patent/FI955463L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI955463A 1993-05-14 1994-05-13 Menetelmä biologisesti aktiivisten polypeptidien tuottamiseksi rekombinanttitekniikalla FI955463L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6104193A 1993-05-14 1993-05-14
PCT/US1994/005354 WO1994026923A1 (en) 1993-05-14 1994-05-13 Method for recombinant production of biologically active polypeptides

Publications (3)

Publication Number Publication Date
FI955463A0 FI955463A0 (fi) 1995-11-13
FI955463A7 FI955463A7 (fi) 1996-01-12
FI955463L true FI955463L (fi) 1996-01-12

Family

ID=22033267

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955463A FI955463L (fi) 1993-05-14 1994-05-13 Menetelmä biologisesti aktiivisten polypeptidien tuottamiseksi rekombinanttitekniikalla

Country Status (13)

Country Link
EP (1) EP0702725B1 (de)
JP (1) JP3578787B2 (de)
KR (1) KR960702868A (de)
CN (1) CN1126494A (de)
AT (1) ATE332392T1 (de)
AU (1) AU692450B2 (de)
CA (1) CA2162865A1 (de)
DE (1) DE69434782T2 (de)
FI (1) FI955463L (de)
HU (1) HU219807B (de)
NO (1) NO954568L (de)
NZ (1) NZ267254A (de)
WO (1) WO1994026923A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910427A (en) * 1995-06-22 1999-06-08 La Jolla Institute For Allergy And Immunology Antigen non-specific glycosylation inhibiting factor derivatives
DE19847690A1 (de) * 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
US7229793B1 (en) * 1999-11-19 2007-06-12 Shire Human Genetic Therapies, Inc. Constructs and cells for production of small peptides
DE19957904A1 (de) * 1999-12-01 2001-06-07 Merck Patent Gmbh Insektengift-Allergene mit verminderter IgE-Reaktivität und Verfahren zu ihrer Herstellung
CA2764377C (en) * 2009-06-10 2018-03-27 Stephen Sanig Research Institute Ltd. Methods of generating cells exhibiting phenotypic plasticity
JP2014526886A (ja) 2011-07-15 2014-10-09 モルフォシス・アー・ゲー マクロファージ遊走阻止因子（ｍｉｆ）とｄ−ドーパクロームトートメラーゼ（ｄ−ｄｔ）に交差反応性がある抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007577A1 (en) * 1987-03-31 1988-10-06 Schering Biotech Corporation Glycosylation inhibiting factors
JPH06508829A (ja) * 1991-06-03 1994-10-06 ラホヤ　インスティチュート　フォア　アレルギー　アンド　イムノロジー サプレッサーｔ細胞ハイブリドーマ
EP0702566B1 (de) * 1993-05-17 2010-07-21 Cytokine Pharmasciences, Inc Inhibition des migrations-inhibitions-faktors in der behandlung von krankheiten bei denen eine cytokin-vermittelte toxizität eine rolle spielt

Also Published As

Publication number Publication date
JP3578787B2 (ja) 2004-10-20
WO1994026923A1 (en) 1994-11-24
AU692450B2 (en) 1998-06-11
JPH0884596A (ja) 1996-04-02
HU9503249D0 (en) 1996-01-29
DE69434782D1 (de) 2006-08-17
KR960702868A (ko) 1996-05-23
HUT73213A (en) 1996-06-28
EP0702725B1 (de) 2006-07-05
FI955463A0 (fi) 1995-11-13
NZ267254A (en) 1997-11-24
NO954568D0 (no) 1995-11-13
FI955463A7 (fi) 1996-01-12
DE69434782T2 (de) 2007-06-14
ATE332392T1 (de) 2006-07-15
NO954568L (no) 1996-01-11
EP0702725A4 (de) 1998-09-30
HU219807B (hu) 2001-08-28
EP0702725A1 (de) 1996-03-27
CN1126494A (zh) 1996-07-10
AU6948894A (en) 1994-12-12
CA2162865A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
FI20090384L (fi) Menetelmä modifioidun G-CSF-polypeptidin valmistamiseksi
FI955132A7 (fi) Menetelmä sementin tuottamiseksi
IS3906A (is) Hliðstæð aðferð við framleiðslu nýrra ísósterískra peptíða
DE69411430D1 (de) Prozesssteuerungssystemarchitektur
FI954657A0 (fi) Biologisesti aktiivisia polypeptidifuusiodimeereja
FI970258L (fi) Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi
DK162890D0 (da) Polypeptid
FI943703L (fi) Menetelmä gamma-butyrolaktonin valmistamiseksi
SE9501285D0 (sv) a process for the production of biologically active proteins
FI921059A7 (fi) Menetelmä hyötyproteiinien erittämiseksi hiivoista
FI955463A7 (fi) Menetelmä biologisesti aktiivisten polypeptidien tuottamiseksi rekombi nanttitekniikalla
FI920058A7 (fi) Menetelmä hirudiinien ja hirudiinin kaltaisten polypeptidien tuottamis eksi rekombinanttitekniikalla
FI960429L (fi) Menetelmä 1,4-butaanidiolin valmistamiseksi
HUP9801438A3 (en) Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
FI945877L (fi) Menetelmä proteiini C:n tuottamiseksi
FI946128A7 (fi) Biologisesti aktiiviset yhdisteet
FI933413A7 (fi) Menetelmä biologisesti aktiivisen, eukaryoottisen, rekombinantti alkaalisen fosfataasin valmistamiseksi
FI962046L (fi) Menetelmä gamma-butyrolaktonin valmistamiseksi
DK44593D0 (da) Fremgangsmaade til fremstilling af et polypeptid
FI945994A7 (fi) Rekombinoitu sellulaasi
FR2701953B1 (fr) Protéine de fusion multi-VIP et procédé de préparation de VIP recombinant.
FI944997A0 (fi) Parannettu rekombinantti-proteiinien tuotanto
FI935592A7 (fi) Menetelmä polypeptidien valmistamiseksi
NO961863D0 (no) Preparater for nematodekontroll
HK1014557A (en) Method for recombinant production of biologically active polypeptides